Exp Clin Endocrinol Diabetes 2012; 120(06): 315-322
DOI: 10.1055/s-0031-1295423
Article
© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Acute Insulin Resistance Following Surgical Trauma in Rats

Y. Jiang
1   Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China
,
G. H. Wu
1   Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China
,
B. Zhang
1   Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China
,
Y. S. Han
1   Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China
,
Q. L. Zhuang
1   Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China
› Author Affiliations
Further Information

Publication History

received 09 September 2011
first decision 20 October 2011

accepted 02 November 2011

Publication Date:
20 December 2011 (online)

Abstract

Objective:

To unravel the possible mechanism of acute posttraumatic insulin resistance in rats.

Methods:

Resection of small intestine was performed to establish the surgical trauma model. The blood glucose and serum insulin level were detected and the HOMA index was calculated. The Hyperinsulinemic-euglycemic clamp was performed to investigate the glucose disposal rate by peripheral tissue. The content and phosphorylation state of IRS-1, p85 of PI3-K and PKB/Akt in skeletal muscle were measured respectively. Finally, the [3H] labeled glucose uptake experiment was carried out.

Results:

The blood glucose elevated significantly after resection of small intestine in rats. The level of serum insulin decreased during the first 30 min after operation but elevated in the following time. The HOMA-IR in trauma group was significantly greater than control group; however the HOMA-β in trauma group was less than control group. The glucose disposal rate was decreased 49% after operation. The p-IRS-1(Ser307) was significantly enhanced 95% after trauma while the p-IRS-1 (Tyr612) was attenuated by 38%. The phosphorylation of its downstream target, p-PKB/Akt(Ser473) was attenuated by 48%. Accordingly, the glucose uptaken by skeletal muscle was significantly decreased in trauma group.

Conclusion:

We demonstrated the posttraumatic insulin resistance occurred soon after surgical trauma in rats. The level of insulin was relatively insufficient because of the decreased sensitivity in peripheral tissue. Trauma induced Ser phosphorylation instead of Tyr phosphorylation eliminated the ability of IRS-1 to activate downstream effector molecules such as PKB/Akt and resulted in severe impairment of insulin signal transduction and glucose transport in skeletal muscle.

 
  • References

  • 1 Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest 2000; 106 (04) 473-481
  • 2 Matthaei S, Stumvoll M, Kellerer M et al. Pathophysiology and pharmacological treatment of insulin resistance. Endocr Rev 2000; 21 (06) 585-618
  • 3 Carlson GL. Insulin resistance in sepsis. Br J Surg 2003; 90 (03) 259-260
  • 4 Desouza C, Gilling L, Fonseca V. Management of the insulin resistance syndrome. Curr Diab Rep 2001; 1 (02) 140-147
  • 5 Schwacha MG, Chaudry IH. The cellular basis of post-burn immunosuppression: macrophages and mediators. Int J Mol Med 2002; 10 (03) 239-243
  • 6 Zhang Q, Carter EA, Ma BY et al. Molecular mechanism(s) of burn-induced insulin resistance in murine skeletal muscle: role of IRS phosphorylation. Life Sci 2005; 77 (24) 3068-3077
  • 7 Thorell A, Efendic S, Gutniak M et al. Development of postoperative insulin resistance is associated with the magnitude of operation. Eur J Surg 1993; 159 (11-12) 593-599
  • 8 Thorell A, Efendic S, Gutniak M et al. Insulin resistance after abdominal surgery. Br J Surg 1994; 81 (01) 59-63
  • 9 den Berghe GV, Wouters P, Weekers F et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345 (19) 1359-1367
  • 10 Van den Berghe G, Wilmer A, Hermans G et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354 (05) 449-461
  • 11 Van den Berghe G, Wilmer A, Milants I et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 2006; 55 (11) 3151-3159
  • 12 Van den Berghe G, Bouillon R, Mesotten D. Glucose control in critically ill patients. N Engl J Med 2009; 361 (01) 89 author reply 91-92
  • 13 Robinson LE, van SMH. Insulin resistance and hyperglycemia in critical illness: role of insulin in glycemic control. AACN Clin Issues 2004; 15 (01) 45-62
  • 14 Jeschke MG, Kraft R, Emdad F et al. Glucose control in severely thermally injured pediatric patients: what glucose range should be the target. Ann Surg 2010; 252 (03) 521-527; discussion 527–528
  • 15 Ballian N, Rabiee A, Andersen DK et al. Glucose metabolism in burn patients: the role of insulin and other endocrine hormones. Burns 2010; 36 (05) 599-605
  • 16 Gauglitz GG, Herndon DN, Jeschke MG. Insulin resistance postburn: underlying mechanisms and current therapeutic strategies. J Burn Care Res 2008; 29 (05) 683-694
  • 17 Mann EA, Mora AG, Pidcoke HF et al. Glycemic control in the burn intensive care unit: focus on the role of anemia in glucose measurement. J Diabetes Sci Technol 2009; 3 (06) 1319-1329
  • 18 Mowery NT, Carnevale RJ, Gunter OL et al. Insulin resistance heralds positive cultures after severe injury. Surg Infect (Larchmt) 2009; 10 (06) 503-509
  • 19 Van Cromphaut SJ, Vanhorebeek I, Van den Berghe G. Glucose metabolism and insulin resistance in sepsis. Curr Pharm Des 2008; 14 (19) 1887-1899
  • 20 Zick Y. Insulin resistance: a phosphorylation-based uncoupling of insulin signaling. Trends Cell Biol 2001; 11 (11) 437-441
  • 21 Li L, Thompson LH, Zhao L et al. Tissue-specific difference in the molecular mechanisms for the development of acute insulin resistance after injury. Endocrinology 2009; 150 (01) 24-32
  • 22 Rui L, Aguirre V, Kim JK et al. Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. J Clin Invest 2001; 107 (02) 181-189
  • 23 Thompson LH, Kim HT, Ma Y, Kokorina NA, Messina JL et al. Acute, muscle-type specific insulin resistance following injury. Mol Med 2008; 14 (11-12) 715-723
  • 24 DeFronzo RA, Jacot E, Jequier E et al. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 1981; 30 (12) 1000-1007
  • 25 Strommer L, Wickbom M, Wang F et al. Early impairment of insulin secretion in rats after surgical trauma. Eur J Endocrinol 2002; 147 (06) 825-833
  • 26 DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237 (03) E214-E223
  • 27 Kraegen EW, James DE, Bennett SP et al. In vivo insulin sensitivity in the rat determined by euglycemic clamp. Am J Physiol 1983; 245 (01) E1-E7
  • 28 Sugita H, Kaneki M, Sugita M et al. Burn injury impairs insulin-stimulated Akt/PKB activation in skeletal muscle. Am J Physiol Endocrinol Metab 2005; 288 (03) E585-E591
  • 29 Strommer L, Permert J, Arnelo U et al. Skeletal muscle insulin resistance after trauma: insulin signaling and glucose transport. Am J Physiol 1998; 275 (2 Pt 1) E351-E358
  • 30 Desouza C, Gilling L, Fonseca V. Management of the insulin resistance syndrome. Curr Diab Rep 2001; 1 (02) 140-147
  • 31 Kendall DM, Harmel AP. The metabolic syndrome, type 2 diabetes, and cardiovascular disease: understanding the role of insulin resistance. Am J Manag Care 2002; 8 (20 Suppl) S635-S653; quiz S654–S657
  • 32 Li L, Messina JL. Acute insulin resistance following injury. Trends Endocrinol Metab 2009; 20 (09) 429-435
  • 33 Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004; 27 (06) 1487-1495
  • 34 Lee J, Pilch PF. The insulin receptor: structure, function, and signaling. Am J Physiol 1994; 266 (2 Pt 1) C319-C334
  • 35 White MF, Kahn CR. The insulin signaling system. J Biol Chem 1994; 269 (01) 1-4
  • 36 Kohn AD, Summers SA, Birnbaum MJ et al. Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J Biol Chem 1996; 271 (49) 31372-31378
  • 37 Haruta T, Uno T, Kawahara J et al. A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1. Mol Endocrinol 2000; 14 (06) 783-794
  • 38 Zhande R, Mitchell JJ, Wu J et al. Molecular mechanism of insulin-induced degradation of insulin receptor substrate 1. Mol Cell Biol 2002; 22 (04) 1016-1026
  • 39 Carlson CJ, White MF, Rondinone CM. Mammalian target of rapamycin regulates IRS-1 serine 307 phosphorylation. Biochem Biophys Res Commun 2004; 316 (02) 533-539
  • 40 Hemi R, Paz K, Wertheim N et al. Transactivation of ErbB2 and ErbB3 by tumor necrosis factor-alpha and anisomycin leads to impaired insulin signaling through serine/threonine phosphorylation of IRS proteins. J Biol Chem 2002; 277 (11) 8961-8969
  • 41 Mothe I, Van Obberghen E. Phosphorylation of insulin receptor substrate-1 on multiple serine residues, 612, 632, 662, and 731, modulates insulin action. J Biol Chem 1996; 271 (19) 11222-11227
  • 42 Klip A, Ramlal T, Young DA et al. Insulin-induced translocation of glucose transporters in rat hindlimb muscles. FEBS Lett 1987; 224 (01) 224-230
  • 43 Wilson CM, Cushman SW. Insulin stimulation of glucose transport activity in rat skeletal muscle: increase in cell surface GLUT4 as assessed by photolabelling. Biochem J 1994; 299 (Pt 3) 755-759
  • 44 Krook A, Kawano Y, Song XM et al. Improved glucose tolerance restores insulin-stimulated Akt kinase activity and glucose transport in skeletal muscle from diabetic Goto-Kakizaki rats. Diabetes 1997; 46 (12) 2110-2114